A Multicenter Study on the Efficacy, Safety and Pharmacokinetics of IgPro10 in Patients With Primary Immunodeficiency (PID).

Trial Profile

A Multicenter Study on the Efficacy, Safety and Pharmacokinetics of IgPro10 in Patients With Primary Immunodeficiency (PID).

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Immunoglobulin G (Primary)
  • Indications Bacterial infections
  • Focus Registrational; Therapeutic Use
  • Sponsors CSL Behring
  • Most Recent Events

    • 05 Jun 2012 Additional trial locations and actual patient number 89 added as reported by ClinicalTrials.gov.
    • 05 Jun 2012 Actual end date (1 Mar 2006) added as reported by ClinicalTrials.gov.
    • 20 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top